MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Biogen Idec (NQ:BIIB)

209.83 -0.82 (-0.39%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 554,817
Open 210.01
Bid (Size) 209.80 (100)
Ask (Size) 211.00 (200)
Prev. Close 210.65
Today's Range 208.22 - 210.79
52wk Range 131.52 - 219.72
Shares Outstanding 146,800,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Biogen (BIIB) Q2 2026 Earnings Call Transcript ↗
Growth portfolio revenue surpassed legacy MS franchise for second consecutive quarter. 
Via The Motley Fool
Topics Earnings
News headline image
Biogen Completes Acquisition of RayThera Inc.
Lead program now in Phase 1 development 
From Biogen Inc.
Via GlobeNewswire

Performance

YTD
+18.0%
+18.0%
1 Month
+0.4%
+0.4%
3 Month
+9.3%
+9.3%
6 Month
+7.3%
+7.3%
1 Year
+51.4%
+51.4%

More News

Read More
News headline image
The 5 Most Interesting Analyst Questions From Biogen’s Q2 Earnings Call
Via StockStory
Topics Earnings
These S&P500 stocks have an unusual volume in today's session ↗
Via Chartmill
News headline image
Why Supernus Pharmaceuticals Stock Topped the Market Today ↗
Via The Motley Fool
News headline image
BIIB Q2 Deep Dive: Portfolio Expansion and Pipeline Readouts Drive Upbeat Outlook
Via StockStory
News headline image
Why Biogen Stock Topped the Market Today ↗
Via The Motley Fool
News headline image
Biogen Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
News headline image
Biogen (NASDAQ:BIIB) Reports Upbeat Q2 CY2026
Via StockStory
News headline image
Biogen (BIIB) Reports Q2: Everything You Need To Know Ahead Of Earnings
Via StockStory
Topics Artificial Intelligence
News headline image
3 Profitable Stocks We Steer Clear Of
Via StockStory
News headline image
Biogen Appoints Michael J. Parini as Chief Legal Officer
From Biogen Inc.
Via GlobeNewswire
News headline image
3 Reasons to Avoid BIIB and 1 Stock to Buy Instead
Via StockStory
Topics Stocks
Discover which S&P500 stocks are making waves on Tuesday. ↗
Via Chartmill
News headline image
Biogen Backs Alzheimer’s Tau Drug for Phase 3 Despite Trial Miss ↗
Via MarketBeat
These S&P500 stocks are moving in today's session ↗
Via Chartmill
What's going on in today's session: S&P500 gap up and gap down stocks ↗
Via Chartmill
News headline image
Biogen Presents Phase 2 CELIA Data at AAIC Demonstrating Meaningful Clinical Outcomes and Robust Tau Reduction with Diranersen in Early Alzheimer’s Disease
From Biogen Inc.
Via GlobeNewswire
News headline image
1 Mid-Cap Stock to Target This Week and 2 We Find Risky
Via StockStory
News headline image
Stock Market Today, July 13: Energy Stocks Cushion Dow as Tech Slides on Geopolitical Tensions ↗
Via The Motley Fool
Topics Economy Stocks
News headline image
1 Healthcare Stock with Solid Fundamentals and 2 We Brush Off
Via StockStory
News headline image
2 Fast-Growing Pharmaceutical Stocks to Buy Now ↗
Via The Motley Fool
News headline image
Biogen Is Paying $1 Billion for a Company That Won't Say What It Makes. Here's Why That's Actually Good News for BIIB Investors. ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
1 S&P 500 Stock with Promising Prospects and 2 We Question
Via StockStory
Topics Energy Stocks
News headline image
Block & Leviton LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of Common Stock of Biogen, Inc. – BIIB
From Block & Leviton LLP
Via GlobeNewswire

Frequently Asked Questions

Is Biogen Idec publicly traded?
Yes, Biogen Idec is publicly traded.
What exchange does Biogen Idec trade on?
Biogen Idec trades on the Nasdaq Stock Market
What is the ticker symbol for Biogen Idec?
The ticker symbol for Biogen Idec is BIIB on the Nasdaq Stock Market
What is the current price of Biogen Idec?
The current price of Biogen Idec is 209.83
When was Biogen Idec last traded?
The last trade of Biogen Idec was at 08/14/26 04:00 PM ET
What is the market capitalization of Biogen Idec?
The market capitalization of Biogen Idec is 30.80B
How many shares of Biogen Idec are outstanding?
Biogen Idec has 31B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story